- Home
- AKYA vs NVRO Comparison
AKYA vs NVRO Comparison
Compare AKYA & NVRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKYA
- NVRO
- Stock Information
- Founded
- AKYA 2015
- NVRO 2006
- Country
- AKYA United States
- NVRO United States
- Employees
- AKYA N/A
- NVRO N/A
- Industry
- AKYA Medical Specialities
- NVRO Medical/Dental Instruments
- Sector
- AKYA Industrials
- NVRO Health Care
- Exchange
- AKYA Nasdaq
- NVRO Nasdaq
- Market Cap
- AKYA 145.5M
- NVRO 139.0M
- IPO Year
- AKYA 2021
- NVRO 2014
- Fundamental
- Price
- AKYA $3.02
- NVRO $4.68
- Analyst Decision
- AKYA Buy
- NVRO Hold
- Analyst Count
- AKYA 7
- NVRO 14
- Target Price
- AKYA $4.40
- NVRO $7.97
- AVG Volume (30 Days)
- AKYA 1.2M
- NVRO 574.3K
- Earning Date
- AKYA 03-03-2025
- NVRO 02-19-2025
- Dividend Yield
- AKYA N/A
- NVRO N/A
- EPS Growth
- AKYA N/A
- NVRO N/A
- EPS
- AKYA N/A
- NVRO N/A
- Revenue
- AKYA $86,815,000.00
- NVRO $419,146,000.00
- Revenue This Year
- AKYA N/A
- NVRO N/A
- Revenue Next Year
- AKYA $11.76
- NVRO $0.50
- P/E Ratio
- AKYA N/A
- NVRO N/A
- Revenue Growth
- AKYA N/A
- NVRO N/A
- 52 Week Low
- AKYA $1.88
- NVRO $3.17
- 52 Week High
- AKYA $6.31
- NVRO $19.47
- Technical
- Relative Strength Index (RSI)
- AKYA 63.45
- NVRO 62.11
- Support Level
- AKYA $2.59
- NVRO $3.17
- Resistance Level
- AKYA $3.10
- NVRO $3.99
- Average True Range (ATR)
- AKYA 0.25
- NVRO 0.31
- MACD
- AKYA 0.04
- NVRO 0.14
- Stochastic Oscillator
- AKYA 65.52
- NVRO 96.81
About AKYA Akoya BioSciences Inc.
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.
About NVRO Nevro Corp.
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.